World Equity Group, Inc. Ardelyx, Inc. Transaction History

World Equity Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$5.89 - $9.31 $14,448 - $22,837	2,453 Added 15.38%	18,402 $136 Million
Q1 2024 Jul 18, 2024	BUY	$6.05 - $9.74 $96,491 - $155,343	15,949 New	15,949 $116 Million
Q4 2023 Jul 22, 2024	SELL	$3.29 - $6.64 $13,278 - $26,799	-4,036 Reduced 21.93%	14,366 $89.1 Million
Q2 2023 Aug 26, 2024	SELL	$3.23 - $4.95 $21,970 - $33,669	-6,802 Reduced 36.96%	11,600 $39.3 Million
Q3 2022 Sep 06, 2024	SELL	$0.59 - $1.44 $4,013 - $9,794	-6,802 Reduced 36.96%	11,600 $13.8 Million
Q1 2022 Sep 06, 2024	SELL	$0.65 - $1.18 $4,421 - $8,026	-6,802 Reduced 36.96%	11,600 $12.4 Million

209

144M

1.01M

1.43M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $756M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

Stay updated on World Equity Group, Inc. with notifications on news.